$1134 Rotary Evaporator 3L Rotary Vacuum Evaporator Lab Scientific Products Lab Instruments Equipment Rotary Direct sale of manufacturer Evaporator Vacuum 3L Vacuum,$1134,/carcinolytic2199385.html,Evaporator,Lab Scientific Products , Lab Instruments Equipment,Rotary,3L,Rotary,Evaporator,diarioregional.mx Vacuum,$1134,/carcinolytic2199385.html,Evaporator,Lab Scientific Products , Lab Instruments Equipment,Rotary,3L,Rotary,Evaporator,diarioregional.mx Rotary Direct sale of manufacturer Evaporator Vacuum 3L $1134 Rotary Evaporator 3L Rotary Vacuum Evaporator Lab Scientific Products Lab Instruments Equipment

Rotary Direct sale of Direct store manufacturer Evaporator Vacuum 3L

Rotary Evaporator 3L Rotary Vacuum Evaporator

$1134

Rotary Evaporator 3L Rotary Vacuum Evaporator

Product description


Introduction

◎ The equipment for purification distillation test rotates and shapes a thin film in negative pressure condition by heating, evaporates efficiently, and then condenses and recollects solvent to purify and separate.

◎ The rotary evaporator can be made into system devices with Circulating Water Vacuum Pump , Vacuum Pump , Low Temperature Circulating Pump, Circulating Cooler, Constant Temperature Reaction Bath , Low Temperature Cooling Liquid Circulating Pump.


Specification

Condenser: Vertical Condenser

Collect Flask: 2L

Rotary Flask: 3L/2L

Motor Power: 60W

Power Voltage: 220/110V for Optional

Bath Power: 1500 W

Bath Volume: 3L

Bath Material: SS304 Combined Bath amp;Teflon Material Completely Closed Heated

Evaporation Rate(Water): 2.5L/ H

Speed Range: 0 - 180 RPM

Lift and Stroke: Automatic Control, 120 mm

Glass Material: GG-17 Glass

Heating Temperature Range: Rm-99 Degree

Heat Control: PID

Heat control accuracy: ±1 Degree

Ultimate Vacuum: 0.098 Mpa

Dimensions (W x H x D):650×520×650 mm

Weight: 40 kg

Rotary Evaporator 3L Rotary Vacuum Evaporator

Opinion

BL Ink

Multimedia

Resources

Portfolio allocation of the cabinet reshuffle

Increase gap between Covishield doses to 12-16 weeks, says expert govt panel

Expert panel recommends Covaxin Phase II & III trials on 2-18 age group